Kura Oncology, Inc.
DE ˙ DB ˙ US50127T1097
7,56 EUR ↑0,24 (3,28%)
2026-06-05
PREȚUL ACȚIUNILOR
SecurityDE:KUR / Kura Oncology, Inc.
InstitutionMorgan Stanley
Latest Disclosed Ownership1,163,977 shares
Latest Disclosed Value $ 9,463,138
Morgan Stanley reports 16.25% decrease in ownership of KUR / Kura Oncology, Inc.

On May 15, 2026 - Morgan Stanley filed a 13F-HR form disclosing ownership of 1,163,977 shares of Kura Oncology, Inc. (DE:KUR) valued at $7,740,447 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on May 27, 2026 disclosing 1,389,828 shares of Kura Oncology, Inc.. This represents a change in shares of -16.25% during the quarter. The current value of the position is $8,799,666 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F KURA ONCOLOGY COM 50127T109 1,163,977 -225,851 -16.25 9,463 -34.47 0.0006
2026-05-27 2025-12-31 13F/A-1 KURA ONCOLOGY COM 50127T109 1,389,828 -423,236 -23.34 14,440 -10.00 0.0009
2026-02-13 2025-12-31 13F KURA ONCOLOGY COM 50127T109 1,389,828 -423,236 14,440 0.0009
2026-05-27 2025-09-30 13F/A-1 KURA ONCOLOGY COM 50127T109 1,813,064 -170,975 -8.62 16,046 40.17 0.0010
2025-11-14 2025-09-30 13F KURA ONCOLOGY COM 50127T109 1,813,064 -170,975 16,046 0.0010
2025-08-15 2025-06-30 13F KURA ONCOLOGY COM 50127T109 1,984,039 60,881 3.17 11,448 -9.81 0.0007
2025-05-15 2025-03-31 13F KURA ONCOLOGY COM 50127T109 1,923,158 -1,350,967 -41.26 12,693 -55.49 0.0009
2025-05-15 2024-12-31 13F/A-1 KURA ONCOLOGY COM 50127T109 3,274,125 2,067,411 171.33 28,518 20.94 0.0020
2025-02-14 2024-12-31 13F KURA ONCOLOGY COM 50127T109 3,274,125 2,067,411 28,518 0.0020
2025-05-14 2024-09-30 13F/A-2 KURA ONCOLOGY COM 50127T109 1,206,714 -121,800 -9.17 23,579 -13.80 0.0017
2025-02-14 2024-09-30 13F/A-1 KURA ONCOLOGY COM 50127T109 1,206,714 -121,800 23,579 0.0017
2024-11-14 2024-09-30 13F KURA ONCOLOGY COM 50127T109 1,206,714 -121,800 23,579 0.0017
2025-05-14 2024-06-30 13F/A-2 KURA ONCOLOGY COM 50127T109 1,328,514 -28,947 -2.13 27,354 -5.53 0.0021
2024-10-17 2024-06-30 13F/A-1 KURA ONCOLOGY COM 50127T109 1,328,514 -28,947 27,354 0.0021
2024-08-14 2024-06-30 13F KURA ONCOLOGY COM 50127T109 1,328,514 -28,947 27,354 0.0021
2024-10-17 2024-03-31 13F/A-2 KURA ONCOLOGY COM 50127T109 1,357,461 26,506 1.99 28,955 51.28 0.0023
2024-08-16 2024-03-31 13F/A-1 KURA ONCOLOGY COM 50127T109 1,357,461 26,506 28,955 0.0023
2024-05-15 2024-03-31 13F KURA ONCOLOGY COM 50127T109 1,357,461 26,506 28,955 0.0023
2024-08-16 2023-12-31 13F/A-1 KURA ONCOLOGY COM 50127T109 1,330,955 1,169,992 726.87 19,139 1,204.64 0.0017
2024-02-13 2023-12-31 13F KURA ONCOLOGY COM 50127T109 1,330,955 1,169,992 19,139 0.0017
2023-11-15 2023-09-30 13F KURA ONCOLOGY COM 50127T109 160,963 -126,764 -44.06 1,468 -51.81 0.0001
2023-08-14 2023-06-30 13F KURA ONCOLOGY COM 50127T109 287,727 76,681 36.33 3,044 17.94 0.0003
2023-05-15 2023-03-31 13F KURA ONCOLOGY COM 50127T109 211,046 -64,746 -23.48 2,581 -24.58 0.0003
2023-02-14 2022-12-31 13F KURA ONCOLOGY COM 50127T109 275,792 -114,716 -29.38 3,423 -35.85 0.0004
2022-11-14 2022-09-30 13F KURA ONCOLOGY COM 50127T109 390,508 -305,292 -43.88 5,334 -58.17 0.0007
2022-10-27 2022-06-30 13F/A-1 KURA ONCOLOGY COM 50127T109 695,800 250,960 56.42 12,753 78.26 0.0017
2022-08-15 2022-06-30 13F KURA ONCOLOGY COM 50127T109 695,800 250,960 12,753 0.0017
2022-10-27 2022-03-31 13F/A-1 KURA ONCOLOGY COM 50127T109 444,840 361,551 434.09 7,154 514.08 0.0010
2022-05-13 2022-03-31 13F KURA ONCOLOGY COM 50127T109 444,840 361,551 7,154 0.0010
2022-02-14 2021-12-31 13F KURA ONCOLOGY COM 50127T109 83,289 -77,738 -48.28 1,165 -61.36 0.0001
2021-11-15 2021-09-30 13F KURA ONCOLOGY COM 50127T109 161,027 -20,484 -11.29 3,015 -20.34 0.0004
2021-08-23 2021-06-30 13F/A-1 KURA ONCOLOGY COM 50127T109 181,511 164,609 973.90 3,785 691.84 0.0005
2021-08-16 2021-06-30 13F KURA ONCOLOGY COM 50127T109 181,511 164,609 3,785 0.0001
2021-05-17 2021-03-31 13F KURA ONCOLOGY COM 50127T109 16,902 -46,338 -73.27 478 -76.85 0.0001
2021-02-16 2020-12-31 13F KURA ONCOLOGY COM 50127T109 63,240 46,607 280.21 2,065 305.70 0.0003
2020-11-13 2020-09-30 13F KURA ONCOLOGY COM 50127T109 16,633 -6,925 -29.40 509 32.55 0.0001
2020-08-14 2020-06-30 13F KURA ONCOLOGY COM 50127T109 23,558 8,874 60.43 384 163.01 0.0001
2020-05-26 2020-03-31 13F/A-1 KURA ONCOLOGY COM 50127T109 14,684 -54,397 -78.74 146 -84.62 0.0000
2020-05-15 2020-03-31 13F KURA ONCOLOGY COM 50127T109 14,684 -54,397 146 11.2158
2020-02-14 2019-12-31 13F KURA ONCOLOGY COM 50127T109 69,081 41,261 148.31 949 124.35 0.0002
2019-11-14 2019-09-30 13F KURA ONCOLOGY COM 50127T109 27,820 2,892 11.60 423 -13.85 0.0001
2019-08-14 2019-06-30 13F KURA ONCOLOGY COM 50127T109 24,928 4,688 23.16 491 46.13 0.0001
2019-05-15 2019-03-31 13F KURA ONCOLOGY COM 50127T109 20,240 -40,088 -66.45 336 -60.28 0.0001
2019-02-14 2018-12-31 13F KURA ONCOLOGY COM 50127T109 60,328 5,314 9.66 846 -12.15 0.0003
2019-04-23 2018-09-30 13F/A-2 KURA ONCOLOGY COM 50127T109 55,014 -25,197 -31.41 963 -34.04 0.0002
2018-11-20 2018-09-30 13F/A-1 KURA ONCOLOGY COM 50127T109 55,014 0 963 0.0002
2018-11-14 2018-09-30 13F KURA ONCOLOGY COM 50127T109 55,014 -25,197 963
2019-04-23 2018-06-30 13F/A-1 KURA ONCOLOGY COM 50127T109 80,211 19,211 31.49 1,460 27.51 0.0004
2018-08-14 2018-06-30 13F KURA ONCOLOGY COM 50127T109 80,211 19,211 1,460
2019-04-23 2018-03-31 13F/A-1 KURA ONCOLOGY COM 50127T109 61,000 -178,382 -74.52 1,145 -68.74 0.0003
2018-05-14 2018-03-31 13F KURA ONCOLOGY COM 50127T109 61,000 -178,382 1,145
2019-04-23 2017-12-31 13F/A-1 KURA ONCOLOGY COM 50127T109 239,382 201,626 534.02 3,663 548.32 0.0010
2018-02-14 2017-12-31 13F KURA ONCOLOGY COM 50127T109 239,382 201,626 3,663
2017-11-14 2017-09-30 13F KURA ONCOLOGY COM 50127T109 37,756 -534,467 -93.40 565 -89.38 0.0002
2017-08-11 2017-06-30 13F KURA ONCOLOGY COM 50127T109 572,223 141,795 32.94 5,321 40.47 0.0016
2017-05-22 2017-03-31 13F/A-1 KURA ONCOLOGY COM 50127T109 430,428 274,166 175.45 3,788 310.85 0.0012
2017-05-12 2017-03-31 13F KURA ONCOLOGY COM 50127T109 430,428 3,788
2017-02-22 2016-12-31 13F/A-1 KURA ONCOLOGY COM 50127T109 156,262 149,372 2,167.95 922 2,044.19 0.0003
2017-02-13 2016-12-31 13F KURA ONCOLOGY COM 50127T109 156,262 922
2016-11-10 2016-09-30 13F KURA ONCOLOGY COM 50127T109 6,890 5,290 330.62 43 975.00 0.0000
2016-08-12 2016-06-30 13F KURA ONCOLOGY COM 50127T109 1,600 1,600 4 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.